Mark C. Wiggins
Chief Business Officer

Mr. Wiggins has substantial experience in marketing and business development activities including several company acquisitions and numerous licensing and global partnering transactions. Prior to joining Mpex in 2009, Mr. Wiggins was employed for 11 years at Biogen Idec where he served most recently as Executive Vice President of Corporate and Business Development, and, prior to that, as Vice President of Marketing and Business Development where he was responsible for all aspects of marketing and reimbursement. He was also a member of the management committee for the collaboration with Genentech on Rituxan®, a drug generating multi-billions of dollars annually and used for treating a number of cancer and autoimmune indications. Prior to Biogen Idec, Mr. Wiggins held a number of senior positions in marketing and business development for Hybridon, Schering-Plough, Johnson&Johnson and Pfizer. Mr. Wiggins received his B.S. degree in finance from Syracuse University and an MBA from the University of Arizona.